Found 7 matching trials
TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer PHASE2 Vast majority of patients with hepatocellular carcinoma (HCC) present with ...
Show More Location
Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
Learn More & Join Trial
Sorafenib Plus TACE Versus Sorafenib Alone as Postoperative Adjuvant Treatment for Resectable Primary Advanced HCC PHASE3 This trial is a multi-center, phase III, randomized (1:1) clinical trial. T...
Show More Location
The First Affiliated Hospital of Sun Yat-sen University
Learn More & Join Trial
Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT PHASE4 Hepatocellular carcinoma (HCC) is the fourth most common cancer in China, w...
Show More Location
Beijing Ditan Hospital, Capital Medical University
Learn More & Join Trial
A Study of ONCO-DOX in Locally Advanced Hepatocellular Carcinoma PHASE3 This is a prospective, multicenter study that will be conducted at up to 40...
Show More Location
University of Alabama Hospital
Learn More & Join Trial
Evaluation Effectiveness and Safety of (cTACE or DEB-TACE + FOLFOX Regimen HAIC) Combined With Camrelizumab and Apatinib Mesylas in the Treatment of Advanced Hepatocellular Carcinoma PHASE2 This study used (cTACE or DEB-TACE + FOLFOX scheme HAIC) combined with PD-1...
Show More Location
Multiple Locations
Learn More & Join Trial
DEB-TACE Plus Lenvatinib or Sorafenib or PD-1 Inhibitor for Unresectable Hepatocellular Carcinoma PHASE3 Transarterial chemoembolization (TACE) based on drug-eluting beads (DEB-TAC...
Show More Location
Guangxi Medical University Cancer Hospital
Learn More & Join Trial
Survival Analysis: TACE vs. Combination Therapy in HCC N/A This retrospective observational study aimed to assess potential improvemen...
Show More Location
First Affiliated Hospital, Medical College of Zhejiang University
Learn More & Join Trial